RecruitingNCT05122962
Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot and Other Congenital Heart Diseases
Sponsor
Mayo Clinic
Enrollment
300 participants
Start Date
Nov 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
This study is being done to determine the mechanism(s) contributing to the onset of symptoms (i.e. shortness of breath and/or palpitations) as well as changes in heart structure in patients with congenital heart disease (CHD)
Eligibility
Min Age: 18 Years
Inclusion Criteria3
- Moderate (or greater) PR based on quantitative Doppler echocardiography.
- Repaired TOF
- Congenital Heart Disease diagnosis including but not limited to Ebstein's anomaly, coarctation of the aorta (COA), Fontan palliation, transposition of the great arteries, congenitally corrected transposition of the great arteries.
Exclusion Criteria2
- Pregnant Women
- Unable to undergo CMRI
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTRemote Heart Rhythm Monitoring
We will be looking to see if remote heart rhythm monitoring for 30 days at baseline, 12, and 24 months, helps for early identification of adverse cardiac events.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05122962
Related Trials
Prenatal Maternal Mental Health and Neurodevelopment in Congenital Heart Disease
NCT067116665 locations
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
NCT052135981 location
Application of a Clinical Decision Support System to Reduce Mechanical Ventilation Duration After Cardiac Surgery in Children
NCT056872921 location
Development of CIRC Technologies
NCT056542721 location
Molecular and Cellular Characterization of Cardiac Tissue in Postnatal Development
NCT002437761 location